419 related articles for article (PubMed ID: 37092854)
1. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors.
Madkour MM; Ramadan WS; Saleh E; El-Awady R
Ann Med; 2023 Dec; 55(1):2203946. PubMed ID: 37092854
[TBL] [Abstract][Full Text] [Related]
2. DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets.
Alagoz M; Gilbert DC; El-Khamisy S; Chalmers AJ
Curr Med Chem; 2012; 19(23):3874-85. PubMed ID: 22788763
[TBL] [Abstract][Full Text] [Related]
3. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements.
Singh D; Khan MA; Siddique HR
Epigenomics; 2023 Apr; 15(8):517-537. PubMed ID: 37313832
[TBL] [Abstract][Full Text] [Related]
4. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z; Ramazi S; Allahverdi A
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
[TBL] [Abstract][Full Text] [Related]
5. Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (
Tang SW; Thomas A; Murai J; Trepel JB; Bates SE; Rajapakse VN; Pommier Y
Clin Cancer Res; 2018 Apr; 24(8):1944-1953. PubMed ID: 29391350
[No Abstract] [Full Text] [Related]
6. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
Toiyama Y; Okugawa Y; Goel A
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases.
Vendetti FP; Rudin CM
Expert Opin Biol Ther; 2013 Sep; 13(9):1273-85. PubMed ID: 23859704
[TBL] [Abstract][Full Text] [Related]
8. Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy.
Hussain S; Tulsyan S; Dar SA; Sisodiya S; Abiha U; Kumar R; Mishra BN; Haque S
Semin Cancer Biol; 2022 Aug; 83():441-451. PubMed ID: 34182144
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic signatures in gastric cancer: current knowledge and future perspectives.
Sogutlu F; Pekerbas M; Biray Avci C
Expert Rev Mol Diagn; 2022 Dec; 22(12):1063-1075. PubMed ID: 36522183
[TBL] [Abstract][Full Text] [Related]
10. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
[TBL] [Abstract][Full Text] [Related]
11. Current paradigms in epigenetic anticancer therapeutics and future challenges.
Singh M; Kumar V; Sehrawat N; Yadav M; Chaudhary M; Upadhyay SK; Kumar S; Sharma V; Kumar S; Dilbaghi N; Sharma AK
Semin Cancer Biol; 2022 Aug; 83():422-440. PubMed ID: 33766649
[TBL] [Abstract][Full Text] [Related]
12. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress.
Neganova ME; Klochkov SG; Aleksandrova YR; Aliev G
Semin Cancer Biol; 2022 Aug; 83():452-471. PubMed ID: 32814115
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation and cancer (review).
Chen QW; Zhu XY; Li YY; Meng ZQ
Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
[TBL] [Abstract][Full Text] [Related]
14. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
15. New anti-cancer strategies: epigenetic therapies and biomarkers.
Balch C; Montgomery JS; Paik HI; Kim S; Kim S; Huang TH; Nephew KP
Front Biosci; 2005 May; 10():1897-931. PubMed ID: 15769674
[TBL] [Abstract][Full Text] [Related]
16. Alteration of DNA Methylation in Gastric Cancer with Chemotherapy.
Choi SJ; Jung SW; Huh S; Chung YS; Cho H; Kang H
J Microbiol Biotechnol; 2017 Aug; 27(8):1367-1378. PubMed ID: 28621113
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifications in spinal ligament aging.
Xiang Q; Zhao Y; Lin J; Jiang S; Li W
Ageing Res Rev; 2022 May; 77():101598. PubMed ID: 35218968
[TBL] [Abstract][Full Text] [Related]
18. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
Gerhauser C
Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
[TBL] [Abstract][Full Text] [Related]
19. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic therapies in patients with solid tumors: Focus on monotherapy with deoxyribonucleic acid methyltransferase inhibitors and histone deacetylase inhibitors.
Katarzyna R; Lucyna B
J Cancer Res Ther; 2019; 15(5):961-970. PubMed ID: 31603095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]